Stockscreener 앱 받기
33.51
0.18%
0.06
시간 외 거래:
33.51
전일 마감가:
$33.45
열려 있는:
$33.49
하루 거래량:
659.97K
Relative Volume:
0.73
시가총액:
$2.66B
수익:
$517.15M
순이익/손실:
$66.35M
주가수익비율:
40.81
EPS:
0.8212
순현금흐름:
$126.63M
1주 성능:
-2.30%
1개월 성능:
+5.24%
6개월 성능:
-7.17%
1년 성능:
+9.51%
1일 변동 폭
$33.29
$34.63
1주일 범위
$32.71
$35.19
52주 변동 폭
$22.61
$50.71
Veracyte Inc Stock (VCYT) Company Profile
명칭
Veracyte Inc
전화
(650) 243-6300
주소
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
Compare VCYT vs TMO, DHR, IDXX, A, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VCYT
Veracyte Inc
|
33.51 | 2.66B | 517.15M | 66.35M | 126.63M | 0.8212 |
TMO
Thermo Fisher Scientific Inc
|
524.57 | 195.48B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
194.54 | 138.36B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
569.01 | 46.31B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
122.09 | 34.18B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
335.23 | 32.95B | 3.17B | 642.63M | 516.49M | 10.77 |
Veracyte Inc Stock (VCYT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-13 | 개시 | Jefferies | Buy |
| 2025-12-02 | 재개 | Morgan Stanley | Underweight |
| 2025-10-20 | 개시 | Canaccord Genuity | Hold |
| 2025-03-20 | 개시 | Craig Hallum | Buy |
| 2024-12-05 | 다운그레이드 | Goldman | Buy → Neutral |
| 2024-11-15 | 개시 | Wolfe Research | Outperform |
| 2024-10-16 | 개시 | UBS | Buy |
| 2024-10-10 | 개시 | Guggenheim | Buy |
| 2024-02-23 | 재확인 | Needham | Buy |
| 2023-01-18 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-01-05 | 개시 | Scotiabank | Sector Outperform |
| 2022-01-07 | 개시 | Stephens | Overweight |
| 2021-11-18 | 재개 | Goldman | Buy |
| 2021-06-15 | 개시 | Raymond James | Outperform |
| 2021-02-18 | 재개 | Needham | Buy |
| 2021-01-28 | 개시 | Truist | Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2020-09-09 | 개시 | Morgan Stanley | Underweight |
| 2019-07-31 | 개시 | Lake Street | Buy |
| 2019-07-02 | 개시 | Needham | Buy |
| 2018-11-29 | 다운그레이드 | Janney | Buy → Neutral |
| 2018-10-31 | 업그레이드 | Janney | Neutral → Buy |
| 2017-11-07 | 다운그레이드 | Janney | Buy → Neutral |
| 2017-11-07 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2017-08-31 | 재개 | BTIG Research | Buy |
| 2016-11-14 | 재개 | Leerink Partners | Outperform |
| 2015-12-18 | 개시 | Cantor Fitzgerald | Buy |
| 2015-06-11 | 재확인 | Leerink Partners | Outperform |
| 2013-11-26 | 개시 | William Blair | Outperform |
모두보기
Veracyte Inc 주식(VCYT)의 최신 뉴스
Emerging Growth Patterns Driving Expansion in the Liquid Biopsy for Cancer Diagnostics Market - openPR.com
VCYT Maintained by Canaccord Genuity -- Price Target Lowered to $40 - GuruFocus
CCORF Maintains Veracyte(VCYT.US) With Hold Rating, Cuts Target Price to $40 - Moomoo
Veracyte Price Target Cut to $40.00/Share From $43.00 by Canaccord Genuity - Moomoo
Is Veracyte (VCYT) Offering Value After Mixed Returns And Conflicting Valuation Signals - Yahoo Finance
Veracyte (VCYT) down 15.4% since last earnings report: Can it rebound? - MSN
Assessing Veracyte (VCYT) Valuation After A Recent Share Price Rebound - Sahm
Sumitomo Mitsui Trust Group Inc. Sells 224,185 Shares of Veracyte, Inc. $VCYT - MarketBeat
Veracyte to Release First Quarter 2026 Financial Results on May 5, 2026 - BioSpace
Veracyte to Release Q1 2026 Results on May 5 - National Today
Veracyte to Release Q1 2026 Earnings on May 5 - National Today
Veracyte (NASDAQ: VCYT) awards 44,221 RSUs to Chief Dev and Tech Officer - Stock Titan
Jefferies Initiates Veracyte(VCYT.US) With Buy Rating, Announces Target Price $45 - 富途牛牛
Veracyte Inc (VCYT) Stock Up 4.3% and Still Undervalued -- GF Sc - GuruFocus
Jefferies initiates coverage of Veracyte (VCYT) with buy recommendation - MSN
VCYT Initiates Coverage by Jefferies -- Price Target Set at $45 - GuruFocus
Veracyte (NASDAQ:VCYT) Coverage Initiated at Jefferies Financial Group - MarketBeat
Jefferies Initiates Veracyte at Buy With $45 Price Target - marketscreener.com
Jefferies initiates Veracyte stock with buy on diagnostics growth - Investing.com UK
Jefferies initiates Veracyte stock with buy on diagnostics growth By Investing.com - Investing.com Canada
Veracyte | 4: Statement of changes in beneficial ownership of securities-Officer Wygant Jonathan - Moomoo
VCYT Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Sentiment Watch: Can Veracyte Inc be the next market leaderPortfolio Gains Report & Free Real-Time Volume Trigger Notifications - baoquankhu1.vn
Veracyte Inc (VCYT) Shares Down 4.29% on Apr 9 - GuruFocus
Rep. Gilbert Ray Cisneros, Jr. Purchases Shares of Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Veracyte Stock Crosses Below 200-Day Moving Average - National Today
Veracyte (NASDAQ:VCYT) Stock Price Crosses Below 200 Day Moving AverageHere's Why - MarketBeat
Veracyte, Inc. (VCYT) Stock forecasts - Yahoo Finance UK
VCYT Technical Analysis & Stock Price Forecast - Intellectia AI
VCYT PE Ratio & Valuation, Is VCYT Overvalued - Intellectia AI
Veracyte Inc (NASDAQ:VCYT) Emerges as a Prime Growth at a Reasonable Price (GARP) Candidate - ChartMill
Emerging Growth Patterns Driving Rapid Expansion in the Oncology Molecular Diagnostics Market - openPR.com
Precision Trading with Veracyte Inc. (VCYT) Risk Zones - Stock Traders Daily
Veracyte (VCYT): Needham Reaffirms "Buy" Rating with $48 Price T - GuruFocus
Veracyte (NASDAQ:VCYT) Given "Buy" Rating at Needham & Company LLC - MarketBeat
Needham Maintains Veracyte(VCYT.US) With Buy Rating, Maintains Target Price $48 - Moomoo
Needham reiterates Veracyte stock rating on bladder cancer test plans By Investing.com - Investing.com South Africa
Needham reiterates Veracyte stock rating on bladder cancer test plans - Investing.com
Veracyte, Inc. (VCYT) stock price, news, quote and history - uk.finance.yahoo.com
Cathie Wood’s ARK buys OpenAI Group stock, sells Veracyte shares By Investing.com - Investing.com UK
Cathie Wood’s ARK buys OpenAI Group stock, sells Veracyte shares - Investing.com
Is Veracyte Stock a Smart Addition to Your Investment Portfolio at This Time? - Bitget
Is Veracyte Stock the Right Pick for Your Portfolio Now? - Yahoo Finance Singapore
MACD Signal: Is Veracyte Inc stock a value trap2026 Top Decliners & Real-Time Price Movement Reports - baoquankhu1.vn
VCYT SEC FilingsVeracyte 10-K, 10-Q, 8-K Forms - Stock Titan
Veracyte price target lowered to $45 from $50 at Guggenheim - TipRanks
Exit Recap: Is Veracyte Inc a strong candidate for buy and hold2026 Analyst Calls & AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Guggenheim Maintains Buy Rating, Lowers Price Target on VCYT to $45 | VCYT Stock News - GuruFocus
Veracyte Inc (VCYT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.57%
0.03%
자본화:
|
볼륨(24시간):